Table 5.
Characteristics1 of HIV-Infected Persons Hospitalized during the Study Period
| Characteristics2 | All periods | 1999–2001 | 2002–2004 | 2005–2007 | p-value3 |
|---|---|---|---|---|---|
| Age, years | 40.7 (10.2) | 39.4 (10.3) | 40.5 (10.2) | 42.6 (9.7) | <0.001 |
|
| |||||
| Female | 204 (11.5%) | 96 (16.4%) | 69 (10.3%) | 39 (7.6%) | 0.11 |
|
| |||||
| Race/ethnicity | 0.99 | ||||
| Caucasian | 775 (43.8%) | 258 (44.0%) | 295 (44.2%) | 222 (43.1%) | |
| African American | 769 (43.4%) | 257 (43.8%) | 283 (42.4%) | 229 (44.5%) | |
| Hispanic | 173 (9.8%) | 55 (9.4%) | 68 (10.2%) | 50 (9.7%) | |
| Other | 53 (3.0%) | 17 (2.9%) | 22 (3.3%) | 14 (2.7%) | |
|
| |||||
| Chronic hepatitis B | 132 (7.5%) | 44 (7.5%) | 56 (8.4%) | 32 (6.2%) | 0.29 |
|
| |||||
| Chronic hepatitis C | 213 (12%) | 47 (8.0%) | 93 (13.9%) | 73 (14.2%) | <0.01 |
|
| |||||
| HIV Duration, years | 9.7 (5.6) | 8.2 (4.5) | 9.8 (5.5) | 11.2 (6.3) | <0.001 |
|
| |||||
| Nadir CD4 count, cells/mm3 | 223 (181) | 212 (183) | 218 (184) | 242 (173) | <0.01 |
|
| |||||
| Proximal CD4 Cell Count, cells/mm3 | 437 (313) | 409 (304) | 437 (327) | 466 (302) | 0.18 |
|
| |||||
| Viral Load, log10 copies/ml | 3.1 (1.5) | 3.3 (1.5) | 3.2 (1.4) | 2.8 (1.4) | <0.001 |
|
| |||||
| Undetectable Viral Load <400 copies/ml | 751 (46.8%) | 238 (46.6%) | 265 (43.4%) | 248 (51.5%) | 0.15 |
|
| |||||
| Currently receiving HAART, yes | 1238 (69.9%) | 396 (67.5%) | 478 (71.6%) | 364 (70.7%) | 0.14 |
|
| |||||
| Duration of HAART Use, years | 5.0 (2.8) | 3.1 (1.3) | 5.2 (2.2) | 7.0 (3.2) | <0.001 |
1
Characteristics were at the visit before hospitalization
2
Values are mean (standard deviation) or number (percentage)
3
P-values examine changes over the three time periods